Bradford S Goodwin - Net Worth and Insider Trading

Bradford S Goodwin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bradford S Goodwin owns 4 companies in total, including Rigel Pharmaceuticals Inc (RIGL) , NeurogesX Inc (NGSX) , and PDL BioPharma Inc (PDLI) among others .

Click here to see the complete history of Bradford S Goodwin’s form 4 insider trades.

Insider Ownership Summary of Bradford S Goodwin

Ticker	Comapny	Transaction Date	Type of Owner
RIGL	Rigel Pharmaceuticals Inc	2007-01-24	director
NGSX	NeurogesX Inc	2012-06-07	director
PDLI	PDL BioPharma Inc	2008-07-16	director & Chairperson of the Board
		2006-05-09	director & Chief Executive Officer

Bradford S Goodwin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Bradford S Goodwin Ownership Network

Ownership Network List of Bradford S Goodwin

No Data

Ownership Network Relation of Bradford S Goodwin

Bradford S Goodwin Owned Company Details

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Bradford S Goodwin is the director of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & Chief Commercial Officer David A Santos .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Bradford S Goodwin made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 14,519 shares made by David A Santos , and a net sale of 12,628 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

What does NeurogesX Inc do?

Who are the key executives at NeurogesX Inc?

Bradford S Goodwin is the director of NeurogesX Inc. Other key executives at NeurogesX Inc include President and CEO Ron Martell , Exec. V.P. & COO & CFO Stephen F Ghiglieri , and director & 10 percent owner Robert Nelsen .

NeurogesX Inc (NGSX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

NeurogesX Inc Insider Transactions

No Available Data

What does PDL BioPharma Inc do?

Who are the key executives at PDL BioPharma Inc?

Bradford S Goodwin is the director & Chairperson of the Board of PDL BioPharma Inc. Other key executives at PDL BioPharma Inc include President and CEO Dominique Monnet , VP & Gen. Counsel & Secretary Christopher Lewis Stone , and VP Finance & CAO and Acting CFO Edward Imbrogno .

PDL BioPharma Inc (PDLI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PDL BioPharma Inc (PDLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDL BioPharma Inc (PDLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PDL BioPharma Inc (PDLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

PDL BioPharma Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Bradford S Goodwin is the director & Chief Executive Officer of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Bradford S Goodwin made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

Bradford S Goodwin Mailing Address

Above is the net worth, insider trading, and ownership report for Bradford S Goodwin. You might contact Bradford S Goodwin via mailing address: 5000 Shoreline Court, Suite 101, South San Francisco Ca 94080.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.